Showing results (41-50 of 158) with videos related to

Sort By:
Pageof 16
Neurotoxicity Research|September 11, 2015
Cannabinoid Ligands and Alcohol Addiction: A Promising Therapeutic Tool or a Humbug?Patrycja Kleczkowska, Irena Smaga, Małgorzata Filip, et al.
Neurotoxicity Research|August 4, 2016
Are Alcohol Anti-relapsing and Alcohol Withdrawal Drugs Useful in Cannabinoid Users?Patrycja Kleczkowska, Irena Smaga, Małgorzata Filip, et al.
Pharmacological Reports : PR|February 10, 2017
Manganese neurotoxicity and protective effects of resveratrol and quercetin in preclinical researchMaciej Gawlik, Małgorzata B Gawlik, Irena Smaga, et al.
European Journal of Pharmacology|May 30, 2006
Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in ratsMagdalena Zaniewska, Andrew C McCreary, Edmund Przegaliński, et al.
Pharmacological Reports : PR|May 3, 2015
Binge eating in pre-clinical modelsBartłomiej Rospond, Joanna Szpigiel, Anna Sadakierska-Chudy, et al.
Neuropharmacology|February 16, 2010
Effects of serotonin (5-HT)2 receptor ligands on depression-like behavior during nicotine withdrawalMagdalena Zaniewska, Andrew C McCreary, Karolina Wydra, et al.
Synapse (New York, N.Y.)|March 3, 2010
Differential effects of serotonin (5-HT)2 receptor-targeting ligands on locomotor responses to nicotine-repeated treatmentMagdalena Zaniewska, Andrew C McCreary, Karolina Wydra, et al.
Brain Research|April 13, 2012
Pharmacological and genetic interventions in serotonin (5-HT)(2C) receptors to alter drug abuse and dependence processesMałgorzata Filip, Umberto Spampinato, Andrew C McCreary, et al.
Pageof 16